FMI opines the parasomnia treatment market was valued at USD 343.10 million in 2025. Sales are expected to reach USD 360.94 million in 2026 and USD 599.23 million by 2036. Non-Rapid Eye Movement is poised to lead by Type with 45.0% share in 2026 and Benzodiazepines is estimated to command by Treatment Type in 2026.